BD to Present at Evercore ISI 5th Annual HealthCONx Conference

Rhea-AI Summary

BD (Becton, Dickinson and Company) (NYSE: BDX) will present virtually at the Evercore ISI 5th Annual HealthCONx Conference on November 29, 2022, at 8:00 am Eastern Time. The presentation will be accessible via BD's investor relations website, with a replay available post-event.

BD is a leading global medical technology firm focused on enhancing health through innovative technologies and solutions. With a workforce of 77,000, BD partners globally to tackle health challenges and improve care delivery.

FRANKLIN LAKES, N.J., Nov. 15, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present virtually at the Evercore ISI 5th Annual HealthCONx Conference on Tuesday, November 29, 2022 at 8:00 am Eastern Time.

The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:
Media:	Investors:
Troy Kirkpatrick	Francesca DeMartino
VP, Public Relations	SVP, Head of Investor Relations
858.617.2361	201.847.5743
troy.kirkpatrick@bd.com	francesca.demartino@bd.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-to-present-at-evercore-isi-5th-annual-healthconx-conference-301679059.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When is BD's presentation at the Evercore ISI 5th Annual HealthCONx Conference?

BD's presentation is scheduled for November 29, 2022, at 8:00 am Eastern Time.

Where can I watch BD's presentation at the HealthCONx Conference?

You can access the live webcast of BD's presentation on their investor relations website.

What is the stock symbol for Becton, Dickinson and Company?

The stock symbol for Becton, Dickinson and Company is BDX.

What is the focus of Becton, Dickinson and Company?

BD focuses on advancing health through innovative medical technologies and solutions.

How many employees does Becton, Dickinson and Company have?

BD has approximately 77,000 employees worldwide.